Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for basal ganglia calcification in hypoparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages 1741-1748

  Goswami, Ravinder ^a   Millo, Tabin ^a   Mishra, Shruti ^a   Das, Madhuchhanda ^a   Kapoor, Mansi ^a   Tomar, Neeraj ^a   Saha, Soma ^a   Roy, Tara Shankar ^a   Sreenivas, Vishnubhatla ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CALCIUM SENSING RECEPTOR; CARBONATE DEHYDRATASE II; GROWTH FACTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RECEPTOR 2; PARATHYROID HORMONE RELATED PROTEIN; SODIUM PHOSPHATE COTRANSPORTER 1; SODIUM PHOSPHATE COTRANSPORTER 2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; VITAMIN D RECEPTOR;

ADULT; ARTICLE; AUTOPSY; CAUDATE NUCLEUS; CONTROLLED STUDY; DEATH; DENSITOMETRY; FAHR DISEASE; FEMALE; GENE EXPRESSION; GRAY MATTER; HUMAN; HUMAN TISSUE; HYPOPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

BASAL GANGLIA DISEASES; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CALCINOSIS; CAUDATE NUCLEUS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; HYPOPARATHYROIDISM; NERVE FIBERS, UNMYELINATED; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING;

EID: 84899899883     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3863     Document Type: Article

References (38)

1. Sachs C, Sjöberg HE, Ericson K. Basal ganglia calcifications on CT: relation to hypoparathyroidism. Neurology. 1982;32:779-782.
2. Rubin MR, Bilezikian JP. Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement. Arq Bras Endocrinol Metabol. 2010;54:220-226.
3. Goswami R, Sharma R, Sreenivas V, Gupta N, Ganapathy A, Das S. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2012;77:200-206.
4. Ohlsson A, Cumming WA, Paul A, S ly WS. Carbonic anhydrase II deficiency syndrome: recessive osteopetrosis with renal tubular acidosis and cerebral calcification. Pediatrics. 1986;77:371-381.
5. Reske-Nielsen E, Lundbae k K, Rafaelsen OJ. Pathological changes in the central and peripheral nervous system of young long-term diabetics. I. Diabetic encephalopathy. Diabetologia. 1965;1:233-344.
6. Bonazza S, La Morgia C, Martinelli P, Capellari S. Strio-pallidodentate calcinosis: a diagnostic approach in adult patients. Neurol Sci. 2011;32:537-545.
7. Norman RM, UriHsieh C.H. The influence of a vascular factor on the distribution of symmetrical cerebral calcifications. J Neurol Neurosurg Psychiatry. 1960;23:142-147.
8. Miklossy J, Mac kenzie IR, Dorovini-Zis K, et al. Severe vascular disturbance in a case of familial brain calcinosis. Acta Neuropathol. 2005;109:643-653.
9. Eaton ML, Camp JD, Love JG. Symmetric cerebra l calcification, particularly of the basal ganglia, demonstrable roentgenographically calcification of the finer cerebral blood vessels. Arch Neurol Psychiatry. 1939;41:921-942.
10. Wang C, Li Y, Shi L, et al. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet. 2012;44:254-256.
11. Goswami R, Mondal AM, Tomar N, et al. Presence of 25(OH)D deficiency and its effect on vitamin D receptor mRNA expression. Eur J Clin Nutr. 2009;63:446-449.
12. Tomar N, Gupta N, Goswami R. Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2013;98:3884-3891.
13. BrenéS, Lindefors N, Ehrlich M, et al. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. J Neurosci. 1994;14:985-998.
14. Lee MC, Ting KK, Adams S, Brew BJ, Chung R, Guillemin GJ. Characterisation of the expression of NMDA receptors in human astrocytes. PLoS One. 2010;5:E14123.
15. Li X Yang HY Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification Circ Res. 2006 98 905-912.
16. Kochanowska I, Chaberek S, Wojtowicz A, et al. Expression of genes for bone morphogenetic proteins BMP-2, BMP-4 and BMP-6 in various parts of the human skeleton.BMCMusculoskelet Disord. 2007;8:128.
17. Bagó AG, Palkovits M, Usdin TB, Seress L, Dobolyi A. Evidence for the expression of parathyroid hormone 2 receptor in the human brainstem. Ideggyogy Sz. 2008;61:123-126.
18. Feeley BT, Liu NQ, Conduah AH, et al. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res. 2006;21:1571-1580.
19. Kanno T, Takahashi T, Ariyoshi W, Tsujisawa T, Haga M, Nishihara T. Tensile mechanical strain up-regulates Runx2 and osteogenic factor expression in human periosteal cells: implications for distraction osteogenesis. J Oral Maxillofac Surg. 2005;63:499-504.
20. Huang L, Teng XY, Cheng YY, Lee KM, Kumta SM. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone. 2004;34: 393-401.
21. Bonanno G, Perillo A, Rutella S, et al. Clinical isolation and functional characterization of cord blood CD133-hematopoietic progenitor cells. Transfusion. 2004;44:1087-1097.
22. Kadkol SS, Lin AY, Barak V, et al. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest Ophthalmol Vis Sci. 2006;47:802-806.
23. Yoshiura K, Nakaoka T, Nishishita T, et al. Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res. 2005;22:8201-8207.
24. Can adillas S, Canalejo A, Santamaría R. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans. J Am Soc Nephrol. 2005;16:2190-2197.
25. Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003;116(Pt 9):1827-1835.
26. Tomar N, Bora H, Singh R, et al. Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members. Eur J Endocrinol. 2010;162:407-421.
27. Goswami R, Brown EM, Kochupillai N, et al. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol. 2004;150:9-18.
28. Hagan CE, Bolon B, Keene CD. Nervous system. In: Treuting PM, Dintzis SM, Frevert CW, Montine KS, eds. Comparative Anatomy and Histology: A Mouse and Human Atlas. 1st ed. San Diego, CA: Academic Press; 2012:339-394.
29. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004; 286:E686-E696.
30. Chester AH. Molecular and cellular mechanisms of valve calcification. Aswan Heart Centre Sci Pract Ser. 2011:4.
31. Doherty TM, Asotra K, Fitzpatrick LA, et al. Calcification in atheroscle rosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A. 2003;100:11201-11206.
32. Ketteler M, Floege J. Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes. Nephrol Dial Transplant. 2006;21:33-35.
33. Savazzi GM, Cusmano F, Musini S. Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis. Nephron. 2001;89:31-36.
34. Krolu Y, Call C, Karabulut N, Oncel C. Intracranial calcifications on CT. Diagn Interv Radiol. 2010;16:263-269.
35. Chen WJ, Yao XP, Zhang QJ, et al. Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification. Gene. 2013;529:159-162.
36. Miy amoto K Haito-Sugino S Kuwahara S et al. Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies J Pharm Sci. 2011 100 3719-3730.
37. Usdin TB, Gruber C, Bonner TI. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem. 1995;270:15455-15458.
38. Smits MG, Gabreels FJ, Froeling PG, de Abreu RA, Thijssen HO, Renier WO. Calcium-phosphate metabolism in autosomal recessive idiopathic strio-pallido-dentate calcinosis and Cockayne's syndrome. Clin Neurol Neurosurg. 1983;85:145-153.